RBRXF (Rhino Biotech) EPS (Diluted) : $-0.00 (TTM As of Dec. 2020)

Rhino Biotech EPS (Diluted) Chart

Rhino Biotech Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EPS (Diluted)		Get a 7-Day Free Trial					-	-	-	-	-

Rhino Biotech Semi-Annual Data
	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EPS (Diluted)	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Rhino Biotech's EPS (Diluted)

For the Shell Companies subindustry, Rhino Biotech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhino Biotech's PE Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Rhino Biotech's PE Ratio distribution charts can be found below:

* The bar in red indicates where Rhino Biotech's PE Ratio falls into.

Rhino Biotech EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Rhino Biotech's Diluted EPS for the fiscal year that ended in Dec. 2020 is calculated as

Rhino Biotech's Diluted EPS for the quarter that ended in Dec. 2020 is calculated as

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhino Biotech  (OTCPK:RBRXF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Rhino Biotech EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Rhino Biotech's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhino Biotech Business Description